ArticleAcute medicine & surgery
Prophylactic Antibiotics and 30-Day Survival in Out-Of-Hospital Cardiac Arrest Patients Undergoing VA-ECMO: A Multicenter Observational Study.
Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with out-of-hospital cardiac arrest (OHCA) undergoing extracorporeal cardiopulmonary resuscitation with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) are at high risk of nosocomial infections, and prophylactic antibiotics may reduce the infections, but there is limited evidence. This study evaluated the effectiveness of prophylactic antibiotic administration on survival and neurological outcomes in patients with OHCA receiving VA-ECMO. Methods: As a prespecified research question within the Survey of Survivors after Cardiac Arrest in the Kanto Area in 2017 (SOS-KANTO 2017) study, we conducted a multicenter observational study analyzing 153 patients with OHCA who underwent VA-ECMO between September 2019 and March 2021. Patients were categorized into the prophylactic antibiotic group ( Results: After Inverse Probability of Treatment Weighting (IPTW), the 30-day survival was significantly higher in the antibiotic group than in the control group (42.8% vs. 20.3%; Conclusions: Prophylactic antibiotic administration during VA-ECMO was associated with improved 30-day survival in patients with OHCA. Although these findings suggest a potential benefit, further randomized controlled trials are required to establish clinical recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.